Ginger supplementation in children with oligoarticular juvenile idiopathic arthritis: A triple-blind randomized...

Area of Science:

• Rheumatology
• Pediatrics
• Pharmacology

Background:

• Juvenile idiopathic arthritis (JIA) is a chronic autoimmune disease affecting children.
• Oligoarticular JIA (oligo-JIA) is the most common subtype, characterized by inflammation in a few joints.
• Current treatments aim to reduce inflammation and prevent joint damage, but novel therapeutic strategies are needed.

Purpose of the Study:

• To investigate the efficacy of ginger (Zingiber officinale) supplementation as an adjunct therapy for oligoarticular juvenile idiopathic arthritis (oligo-JIA).
• To evaluate the impact of ginger on treatment response criteria in pediatric patients with oligo-JIA.

Main Methods:

• A randomized controlled trial involving 40 children (ages 6-16) diagnosed with oligo-JIA.
• Participants received either ginger capsules (250 mg twice daily) or a placebo for three months, alongside standard treatment.
• Treatment response was assessed using American College of Rheumatology Pediatric (ACR-Pedi) 30, 50, 70, and 90 criteria.

Main Results:

• Ginger supplementation led to statistically significant improvements in ACR-Pedi 30, 50, 70, and 90 response rates compared to placebo (p<0.001 for 30, 50, 70; p=0.001 for 90).
• These findings indicate enhanced therapeutic outcomes with the addition of ginger.

Conclusions:

• Ginger supplementation demonstrated a positive effect on improving ACR-Pedi response criteria in pediatric patients with oligo-JIA.
• Ginger's anti-inflammatory and immunomodulatory properties suggest its potential as a safe and effective complementary therapy.
• Further research is warranted to confirm these findings and explore optimal dosing and long-term effects.